KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Change in Cash (2016 - 2025)

Humana (HUM) has disclosed Change in Cash for 16 consecutive years, with $1.3 billion as the latest value for Q3 2025.

  • On a quarterly basis, Change in Cash changed N/A to $1.3 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $11.8 billion, a N/A change, with the full-year FY2024 number at -$2.5 billion, down 573.84% from a year prior.
  • Change in Cash was $1.3 billion for Q3 2025 at Humana, up from -$210.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $8.7 billion in Q1 2023 to a low of -$8.5 billion in Q4 2022.
  • A 4-year average of $1.2 billion and a median of $926.0 million in 2021 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: plummeted 145.0% in 2021, then surged 800.43% in 2022.
  • Humana's Change in Cash stood at $926.0 million in 2021, then plummeted by 1017.6% to -$8.5 billion in 2022, then surged by 202.08% to $8.7 billion in 2023, then plummeted by 84.46% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Change in Cash are $1.3 billion (Q3 2025), -$210.0 million (Q2 2025), and $2.0 billion (Q1 2025).